DSFCL Reports Audited FY26 Results: Net Loss of ₹408 Lakhs, Recommends Dividend
DCM Shriram Fine Chemicals Limited reported a consolidated net loss after tax of ₹408 lakhs for Q4 FY26, compared to a profit of ₹427 lakhs in Q4 FY25. For FY26, the consolidated net profit after tax was ₹1,845 lakhs. The company recommended a final dividend of ₹0.40 per share. The results reflect a composite scheme of arrangement which became effective in December 2025.
The financial results show a shift from profit to loss for the quarter, which is a material event. The impact of a significant corporate restructuring and the recommended dividend also contribute to a medium impact.
The company reported a net loss for the quarter ended March 31, 2026, which is a negative financial outcome compared to the profit reported in the corresponding prior period. While a dividend recommendation is positive, the overall financial performance for the quarter is negative.
DCM Shriram Fine Chemicals Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a consolidated net loss after tax of ₹408 lakhs for the quarter ended March 31, 2026, compared to a net profit of ₹427 lakhs in the same period last year. For the full financial year ended March 31, 2026, the consolidated net profit after tax was ₹1,845 lakhs.
The company's total income from operations for the quarter stood at ₹9,351 lakhs, while for the full year it was ₹38,771 lakhs on a consolidated basis.
The Board of Directors, in its meeting held on May 19, 2026, recommended a final dividend of ₹0.40 per equity share of face value ₹2 each for the financial year ended March 31, 2026, subject to shareholders' approval.
The results reflect the impact of a Composite Scheme of Arrangement approved by the NCLT, which became effective on December 17, 2025. This scheme involved the amalgamation of Lily Commercial Private Limited with DCM Shriram Industries Limited and the subsequent demerger of chemical and rayon undertakings into DCM Shriram Fine Chemicals Limited and DSIL. As part of the scheme, DCM Shriram Industries Limited transferred net assets aggregating ₹15,336 lakhs and a surplus of ₹28,663 lakhs to the company. Additionally, 8,69,92,185 equity shares of ₹2 each were allotted to the shareholders of DCM Shriram Industries Limited on December 31, 2025, and listed on February 17, 2026.
The company also recognized an impairment loss of ₹533 lakhs on the disposal of leasehold land in Dahej, Gujarat, which was subsequently reversed by ₹223 lakhs upon sale. A reversal of input tax credit amounting to ₹229.02 lakhs was also recorded due to the withdrawal of a GST refund application. The company assessed the potential financial impact of the new Labour Codes and concluded there is no material financial impact based on the existing remuneration structure.
What to do with a filing like this
DCM Shriram Fine Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Fine Chemicals Limited. Read the original for the full detail.